Company Overview of Psyadon Pharmaceuticals, Inc.
Psyadon Pharmaceuticals, Inc. engages in the discovery and development of drugs for the treatment of diseases afflicting the central nervous system, primarily neurological and psychiatric diseases. Its Ecopipam product is an antagonist of the D1 dopamine receptor that blocks the actions of the neurotransmitter dopamine at the D1 receptor-family in the brain. Psyadon Pharmaceuticals, Inc. was formerly known as Ruxton Pharmaceuticals, Inc. and changed its name in November 2008. The company was founded in 2004 and is based in Germantown, Maryland.
20451 Seneca Meadows Parkway
Germantown, MD 20876
Founded in 2004
Key Executives for Psyadon Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Psyadon Pharmaceuticals, Inc., please visit www.psyadonrx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.